Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Advanced Corneal Hydrogels: From Passive Replacement to Active Regeneration and Intelligent Interaction

Wang X., Zhou W., Xue H., Xue W., Gao G., Zhu B.

Narrative Review on Chronic Wound, Scar, published in Adv Sci (Weinh) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Sci (Weinh) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41736701
PMCID
PMC13045501
DOI
10.1002/advs.202522362

Abstract (original English)

Hydrogels represent a transformative solution for corneal pathologies, offering the advantages of transparency, biocompatibility, and structural tunability to address the global donor tissue shortage. This review establishes a comprehensive framework for material design by delineating critical requirements, including optical clarity, mechanical anisotropy, and stable wet adhesion within dynamic ocular environments. The performances of natural, synthetic, and decellularized-matrix hydrogels are systematically compared to elucidate the structure-property relationships essential for recapitulating native corneal physiology. Beyond passive substitution, the transition toward bioactive regeneration is examined through analyses of scarless wound healing, sustained drug delivery, and stimuli-responsive implants. Furthermore, the integration of advanced technologies is evaluated with a focus on three-/four-dimensional bioprinting for hierarchical architectural reconstruction and hydrogel-based wearable bioelectronics for real-time sensing. Finally, pivotal clinical translation bottlenecks, ranging from sterilization to long-term immunocompatibility, are identified to guide the development of next-generation personalized and intelligent corneal devices.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
CorneaAnimalsHumansBiocompatible MaterialsHydrogelsTissue EngineeringRegenerationWound HealingPrinting, Three-Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research